Effect of Hydroxysafflor yellow A on human umbilical vein endothelial cells under hypoxia. 2009

Deng Bo Ji, and Li Yun Zhang, and Chang Ling Li, and Jia Ye, and Hai Bo Zhu
Department of Molecular and Cellular Pharmacology, School of Pharmaceutical Sciences, Peking University, Beijing, 100191, China.

Hydroxysafflor yellow A (HSYA), is a component of the flower, Carthamus tinctorius L. In this study, we investigated its effect on Human Umbilical Vein Endothelial Cells (HUVECs) under hypoxia. We evaluated cell viability using the MTT kit. The cell cycle distribution was analyzed by PI staining flow cytometric analysis. PI AnnexinV-FITC detection and the TUNEL assay were performed to evaluate the apoptosis rate. Nitric oxide (NO) generation in cell supernatant was measured by the Griess assay. RT-PCR, Western blot and Immunocytochemistry analysis were used to evaluate the changes of Bcl-2, Bax, p53 and eNOS. Our data showed that HSYA inhibited cell apoptosis and cell cycle G1 arrest induced by hypoxia. HSYA treatment increased the Bcl-2/Bax ratio of protein and mRNA, reduced p53 protein expression in cell nucleus. In addition, HSYA enhanced the NO content of cell supernatant under hypoxia, accompanied with upregulating eNOS mRNA expression and protein level. Taken together, these results demonstrate that HSYA could protect HUVECs from hypoxia induced injuries by inhibiting cell apoptosis and cell cycle arrest. These findings have partly revealed the molecular mechanism of HSYA on treating of ischemic heart disease. We expected our experiments might provide some clues for further research.

UI MeSH Term Description Entries
D011247 Pregnancy The status during which female mammals carry their developing young (EMBRYOS or FETUSES) in utero before birth, beginning from FERTILIZATION to BIRTH. Gestation,Pregnancies
D011809 Quinones Hydrocarbon rings which contain two ketone moieties in any position. They can be substituted in any position except at the ketone groups.
D002453 Cell Cycle The complex series of phenomena, occurring between the end of one CELL DIVISION and the end of the next, by which cellular material is duplicated and then divided between two daughter cells. The cell cycle includes INTERPHASE, which includes G0 PHASE; G1 PHASE; S PHASE; and G2 PHASE, and CELL DIVISION PHASE. Cell Division Cycle,Cell Cycles,Cell Division Cycles,Cycle, Cell,Cycle, Cell Division,Cycles, Cell,Cycles, Cell Division,Division Cycle, Cell,Division Cycles, Cell
D002478 Cells, Cultured Cells propagated in vitro in special media conducive to their growth. Cultured cells are used to study developmental, morphologic, metabolic, physiologic, and genetic processes, among others. Cultured Cells,Cell, Cultured,Cultured Cell
D002599 Chalcone An aromatic KETONE that forms the core molecule of CHALCONES. Benzalacetophenone,Benzylideneacetophenone,1,3-Diphenyl-2-Propen-1-One,Chalkone,1,3 Diphenyl 2 Propen 1 One
D004730 Endothelium, Vascular Single pavement layer of cells which line the luminal surface of the entire vascular system and regulate the transport of macromolecules and blood components. Capillary Endothelium,Vascular Endothelium,Capillary Endotheliums,Endothelium, Capillary,Endotheliums, Capillary,Endotheliums, Vascular,Vascular Endotheliums
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D014471 Umbilical Veins Venous vessels in the umbilical cord. They carry oxygenated, nutrient-rich blood from the mother to the FETUS via the PLACENTA. In humans, there is normally one umbilical vein. Umbilical Vein,Vein, Umbilical,Veins, Umbilical
D015687 Cell Hypoxia A condition of decreased oxygen content at the cellular level. Anoxia, Cellular,Cell Anoxia,Hypoxia, Cellular,Anoxia, Cell,Anoxias, Cell,Anoxias, Cellular,Cell Anoxias,Cell Hypoxias,Cellular Anoxia,Cellular Anoxias,Cellular Hypoxia,Cellular Hypoxias,Hypoxia, Cell,Hypoxias, Cell,Hypoxias, Cellular

Related Publications

Deng Bo Ji, and Li Yun Zhang, and Chang Ling Li, and Jia Ye, and Hai Bo Zhu
January 2020, Evidence-based complementary and alternative medicine : eCAM,
Deng Bo Ji, and Li Yun Zhang, and Chang Ling Li, and Jia Ye, and Hai Bo Zhu
June 2019, Human & experimental toxicology,
Deng Bo Ji, and Li Yun Zhang, and Chang Ling Li, and Jia Ye, and Hai Bo Zhu
September 2016, Pharmaceutical biology,
Deng Bo Ji, and Li Yun Zhang, and Chang Ling Li, and Jia Ye, and Hai Bo Zhu
April 2009, Zhonghua fu chan ke za zhi,
Deng Bo Ji, and Li Yun Zhang, and Chang Ling Li, and Jia Ye, and Hai Bo Zhu
November 2016, Acta Cardiologica Sinica,
Deng Bo Ji, and Li Yun Zhang, and Chang Ling Li, and Jia Ye, and Hai Bo Zhu
January 2015, PloS one,
Deng Bo Ji, and Li Yun Zhang, and Chang Ling Li, and Jia Ye, and Hai Bo Zhu
January 2020, Clinics (Sao Paulo, Brazil),
Deng Bo Ji, and Li Yun Zhang, and Chang Ling Li, and Jia Ye, and Hai Bo Zhu
August 2004, Biochemical and biophysical research communications,
Deng Bo Ji, and Li Yun Zhang, and Chang Ling Li, and Jia Ye, and Hai Bo Zhu
October 2019, Acta biomaterialia,
Deng Bo Ji, and Li Yun Zhang, and Chang Ling Li, and Jia Ye, and Hai Bo Zhu
April 2012, Zhongguo Zhong yao za zhi = Zhongguo zhongyao zazhi = China journal of Chinese materia medica,
Copied contents to your clipboard!